This could be because older patients who are on insulin therapy receive more instructions and precautionary advice from their treating physicians because it is a high-risk medication associated with hypoglycaemia, and thus they know more about their expected hypoglycaemic event and can manage it better. The gene discussed is INS; the disease is Hypoglycemia.